E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/27/2006 in the Prospect News Biotech Daily.

Zimmer still at market underperform by JMP

Zimmer Holdings, Inc. was kept at market underperform by JMP Securities analyst Robert C. Faulkner due to the company's declining sales estimates, earnings per share estimates and long-term deceleration in its core markets. JMP's 2006 earnings per share estimate was reduced to $3.40 from $3.47. Shares of the Warsaw, Ind., medical device company were down $3.64, or 5.54%, at $62.10 on volume of 7,589,800 shares versus the three-month running average of 1,507,720 shares. (NYSE: ZMH)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.